BuildingCensus
–

Teikoku Usa Pharma

Laboratory in California, CA · 1718 Ringwood Avenue, San Jose · 95131

At a glance

Teikoku Usa Pharma is a 54,000-square-foot laboratory building at 1718 Ringwood Avenue, San Jose in San Jose, California, built in 2003. In its 2024 California benchmarking disclosure it reported a site energy-use intensity of 106.6 kBtu/ft² and 354 tCO₂e of greenhouse-gas emissions.

ENERGY STAR score
—
not reported · 2024
Site EUI
106.6
kBtu/ft²
GHG emissions
354
tCO₂e
GHG intensity
6.6
kgCO₂e/ft²
Floor area
54,000
sq ft
Year built
2003
vintage
◆ Loading map…
85–10070–8455–691–54
This entry + 6 nearby

AB 802 (Public Resources Code §25402.10) · reporting year 2024

Benchmarking record

FieldValue
ENERGY STAR score—
Site EUI106.6 kBtu/ft²
Source EUI—
GHG emissions354 tCO₂e
GHG intensity6.6 kgCO₂e/ft²
Electricity1,264,657 kWh
Gross floor area54,000 sq ft
Source recordcalifornia:6769740:2024

The disclosure history

Year over year

YearScoreΔSite EUIGHG emissions
2024latest—106.6 kBtu/ft²354 tCO₂e
2023—110.8 kBtu/ft²404 tCO₂e
2022—110.2 kBtu/ft²392 tCO₂e
2020—118.9 kBtu/ft²411 tCO₂e
2019—119.9 kBtu/ft²436 tCO₂e

Compliance context

AB 802 (Public Resources Code §25402.10)

AB 802 requires every California commercial building over 50,000 sq ft to report energy use to the CEC annually; the CEC publicly discloses the results statewide.

Program details →

Ownership

No owning organisation shown. Names of private individuals in the disclosure are not published here.

Own or manage this building? Claim it to correct the record and get compliance alerts.

Location

Address
1718 Ringwood Avenue, San Jose
State
California
ZIP
95131
Coordinates
37.38859, -121.89104

Within ~1 km

Nearby benchmarked buildings

See also: most efficient in California · biggest emitters

How does Teikoku Usa Pharma compare with other laboratory buildings in California?

The latest disclosures cover 308 laboratory buildings in California, out of 40,029 buildings citywide. Its site EUI of 106.6 kBtu/ft² is about 41% below the average of 181.8 kBtu/ft² — it uses less energy per square foot than the typical building in that group. Its emissions intensity of 6.6 kgCO₂e/ft² is about 41% below the group average of 11.1 kgCO₂e/ft².

At 54,000 sq ft, it is about 56% below the average floor area of 121,485 sq ft for those buildings. It was built in 2003, 11 years later than the group's average year built (1992). Across all 24 jurisdictions BuildingCensus covers, the 795 laboratory buildings average an ENERGY STAR score of 29 and a site EUI of 231.7 kBtu/ft².

How has Teikoku Usa Pharma's energy performance changed over time?

BuildingCensus holds 5 California disclosures for Teikoku Usa Pharma, covering report years 2019, 2020, 2022, 2023, 2024. Site EUI moved from 119.9 kBtu/ft² (2019) to 106.6 kBtu/ft² (2024), a 11% decrease. Reported emissions went from 436 tCO₂e to 354 tCO₂e over the same span (down 19%).

What does a site EUI of 106.6 kBtu/ft² mean?

Site energy-use intensity (EUI) is the energy a building uses on site in a year divided by its floor area, in thousand Btu per square foot — lower is more efficient. Teikoku Usa Pharma's 106.6 kBtu/ft² across 54,000 sq ft works out to about 5.8 billion Btu (1,687 MWh-equivalent) in 2024. The disclosure also reports 1,264,657 kWh of electricity for the year.

Which law requires Teikoku Usa Pharma to report its energy use?

Teikoku Usa Pharma reports under AB 802 (Public Resources Code §25402.10), the legal basis of California's Building Energy Benchmarking Program (statewide), which publishes each covered building's annual benchmarking results. The record shown here is the report-year 2024 disclosure (source record california:6769740:2024). AB 802 requires every California commercial building over 50,000 sq ft to report energy use to the CEC annually; the CEC publicly discloses the results statewide.

More laboratory buildings in California

Frequently asked questions

What is Teikoku Usa Pharma's energy grade?

Teikoku Usa Pharma did not report an ENERGY STAR score in its 2024 disclosure, but its site energy-use intensity was 106.6 kBtu/ft².

How much energy does Teikoku Usa Pharma use?

Its 2024 site energy-use intensity was 106.6 kBtu/ft² across 54,000 sq ft, including 1,264,657 kWh of electricity.

What are Teikoku Usa Pharma's carbon emissions?

Teikoku Usa Pharma reported 354 tCO₂e of greenhouse-gas emissions (6.6 kgCO₂e/ft²) for 2024.

Where is Teikoku Usa Pharma?

Teikoku Usa Pharma is at 1718 Ringwood Avenue, San Jose, in San Jose, California 95131. Its coordinates are 37.38859, -121.89104 (latitude, longitude), as published in the Building Energy Benchmarking Program (statewide) file.

How big is Teikoku Usa Pharma and when was it built?

Teikoku Usa Pharma has 54,000 sq ft of gross floor area, as reported in its 2024 disclosure. The disclosure lists 2003 as its year built. It is classed as laboratory.

Is Teikoku Usa Pharma covered by AB 802 (Public Resources Code §25402.10)?

Yes — it appears in the 2024 Building Energy Benchmarking Program (statewide) disclosure, which lists the buildings reporting under AB 802 (Public Resources Code §25402.10).

Working with California building benchmarking records? Pro adds alerts, change history and CSV export ($49/mo); Enterprise adds full national files, the API and an MCP server for AI tools.

About this data

Source: Building Energy Benchmarking Program (statewide) (AB 802 (Public Resources Code §25402.10)), as published July 9, 2026. See the methodology for how records are matched, cleaned and scored.

Cite as: BuildingCensus, “Teikoku Usa Pharma, San Jose, California — 2024 benchmarking disclosure”, https://buildingcensus.com/buildings/california/teikoku-usa-pharma-e8311a57 (data as of July 9, 2026).